Background: While psychological interventions are effective at improving symptoms of psychosis, accessible, cost- and time-efficient treatments remain limited. Personalized medicine has emerged as a promising approach, tailoring interventions to individual needs. Metacognitive Training (MCT), with its established efficacy and adaptable format, is well-suited for personalization. The PERMEPSY project (Towards a Personalized Medicine Approach to Psychological Treatment for Psychosis) aims to deliver tailored MCT intervention for individuals with psychosis.
Methods: PERMEPSY is an international study funded by ERAPerMed (JTC2022) involving five clinical partners (Spain, Chile, France, Germany, Poland) and one technological partner (Spain). The project involves a proof-of-concept clinical trial recruiting 51 participants from each center for a total of 255 adult participants with psychosis in a prospective study (Registration: NCT06603922, 19-09-2024). The trial will test the efficacy of a Machine Learning (ML)-derived platform at predicting clinical and functional outcomes from baseline scores and compare a personalized MCT (P-MCT) to a classical MCT based on the platform's predictions.
Aims: PERMEPSY seeks to (1) develop and test the predictive power of an algorithm that could support decision-making, and (2) ascertain whether P-MCT is more effective than MCT at improving key symptoms and cognitive impairments associated to psychosis.
Results: A harmonized retrospective database enabled the development of a predictive ML algorithm, integrated into an innovative platform. This platform provides clinicians with the information needed to deliver P-MCT. Predictions include changes in positive symptoms (e.g., delusions), insight, self-esteem, and treatment adherence.
Discussion: By integrating diverse data types and innovative technology, PERMEPSY addresses the need for personalized, effective treatment in psychosis, aiming to reduce individual and systemic burdens while supporting clinicians in their decision-making.
{"title":"PERMEPSY: a multicentre, randomized, double-blind proof-of-concept trial of personalized metacognitive training for adults with psychosis - a study protocol.","authors":"Maria Lamarca, Claudia Requejo, Adrianna Aleksandrowicz, Adrien Goncalves, Martyna Kreżołek, Hanna Gelner, Justyna Piwińska, Rabea Fischer, Merle Schlechte, Alvaro Cavieres, Vanessa Acuña, Fabrice Berna, Steffen Moritz, Caroline König, Łukasz Gawęda, Susana Ochoa","doi":"10.3389/fpsyt.2026.1711659","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1711659","url":null,"abstract":"<p><strong>Background: </strong>While psychological interventions are effective at improving symptoms of psychosis, accessible, cost- and time-efficient treatments remain limited. Personalized medicine has emerged as a promising approach, tailoring interventions to individual needs. Metacognitive Training (MCT), with its established efficacy and adaptable format, is well-suited for personalization. The PERMEPSY project (Towards a Personalized Medicine Approach to Psychological Treatment for Psychosis) aims to deliver tailored MCT intervention for individuals with psychosis.</p><p><strong>Methods: </strong>PERMEPSY is an international study funded by ERAPerMed (JTC2022) involving five clinical partners (Spain, Chile, France, Germany, Poland) and one technological partner (Spain). The project involves a proof-of-concept clinical trial recruiting 51 participants from each center for a total of 255 adult participants with psychosis in a prospective study (Registration: NCT06603922, 19-09-2024). The trial will test the efficacy of a Machine Learning (ML)-derived platform at predicting clinical and functional outcomes from baseline scores and compare a personalized MCT (P-MCT) to a classical MCT based on the platform's predictions.</p><p><strong>Aims: </strong>PERMEPSY seeks to (1) develop and test the predictive power of an algorithm that could support decision-making, and (2) ascertain whether P-MCT is more effective than MCT at improving key symptoms and cognitive impairments associated to psychosis.</p><p><strong>Results: </strong>A harmonized retrospective database enabled the development of a predictive ML algorithm, integrated into an innovative platform. This platform provides clinicians with the information needed to deliver P-MCT. Predictions include changes in positive symptoms (e.g., delusions), insight, self-esteem, and treatment adherence.</p><p><strong>Discussion: </strong>By integrating diverse data types and innovative technology, PERMEPSY addresses the need for personalized, effective treatment in psychosis, aiming to reduce individual and systemic burdens while supporting clinicians in their decision-making.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1711659"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1742330
Lucas Ferrer Nappe
{"title":"From mechanisms to meanings: toward a content-sensitive psychiatry.","authors":"Lucas Ferrer Nappe","doi":"10.3389/fpsyt.2026.1742330","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1742330","url":null,"abstract":"","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1742330"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1716253
Camille Duveau, Pablo Nicaise, Pierre Smith, Katharina Seeber, Richard Bryant, Giovanni Corrao, Mireia Félez-Nóbrega, Josep Maria Haro, Irwin Hecker, Kerry Rodríguez McGreevy, Roberto Mediavilla, Maria Melchior, Ellenor Mittendorfer-Rutz, Matteo Monzio Compagnoni, Papoula Petri-Romão, Antje Riepenhausen, Jutta Stoffers-Winterling, Anke Witteveen, Marit Sijbrandij, Vincent Lorant
Introduction: Longitudinal studies have identified an increase in psychological distress throughout the general population during the COVID-19 pandemic. Nevertheless, the determinants of the variation in psychological distress are unclear. This paper investigated factors that were likely to be associated with psychological distress variation: exposure to COVID-19 and psychosocial factors.
Methods: Five waves of a prospective cohort survey were conducted with a convenience sample of the general population in Belgium between March 2020 and November 2021 (n=4,550). Psychological distress was measured using the GHQ-12. Two groups of exposures were investigated: self-reported exposure to COVID-19 and psychosocial factors (loneliness, social support, and social activities). We first partitioned the variance into an interindividual component (time-invariant) and an intraindividual component (time-variant). Linear mixed models were used for analysis.
Results: Most of the variance in psychological distress was interindividual. For both sources of variance (interindividual and intraindividual), the change in psychological distress was mainly associated with psychosocial factors, rather than pandemic-related factors. Loneliness emerged as the factor most strongly associated both with interindividual and intraindividual differences in psychological distress.
Discussion: Overall, these findings suggest that the variation in psychological distress between the waves was mostly influenced by social support, loneliness, and social activities, rather than by exposure to COVID-19. Mitigation policies aimed at controlling the pandemic should focus more on addressing specific individual psychosocial vulnerabilities.
{"title":"Dynamics of psychological distress: understanding the impact of intraindividual and interindividual factors in the Belgian population during the COVID-19 pandemic-a multilevel prospective cohort study.","authors":"Camille Duveau, Pablo Nicaise, Pierre Smith, Katharina Seeber, Richard Bryant, Giovanni Corrao, Mireia Félez-Nóbrega, Josep Maria Haro, Irwin Hecker, Kerry Rodríguez McGreevy, Roberto Mediavilla, Maria Melchior, Ellenor Mittendorfer-Rutz, Matteo Monzio Compagnoni, Papoula Petri-Romão, Antje Riepenhausen, Jutta Stoffers-Winterling, Anke Witteveen, Marit Sijbrandij, Vincent Lorant","doi":"10.3389/fpsyt.2026.1716253","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1716253","url":null,"abstract":"<p><strong>Introduction: </strong>Longitudinal studies have identified an increase in psychological distress throughout the general population during the COVID-19 pandemic. Nevertheless, the determinants of the variation in psychological distress are unclear. This paper investigated factors that were likely to be associated with psychological distress variation: exposure to COVID-19 and psychosocial factors.</p><p><strong>Methods: </strong>Five waves of a prospective cohort survey were conducted with a convenience sample of the general population in Belgium between March 2020 and November 2021 (n=4,550). Psychological distress was measured using the GHQ-12. Two groups of exposures were investigated: self-reported exposure to COVID-19 and psychosocial factors (loneliness, social support, and social activities). We first partitioned the variance into an interindividual component (time-invariant) and an intraindividual component (time-variant). Linear mixed models were used for analysis.</p><p><strong>Results: </strong>Most of the variance in psychological distress was interindividual. For both sources of variance (interindividual and intraindividual), the change in psychological distress was mainly associated with psychosocial factors, rather than pandemic-related factors. Loneliness emerged as the factor most strongly associated both with interindividual and intraindividual differences in psychological distress.</p><p><strong>Discussion: </strong>Overall, these findings suggest that the variation in psychological distress between the waves was mostly influenced by social support, loneliness, and social activities, rather than by exposure to COVID-19. Mitigation policies aimed at controlling the pandemic should focus more on addressing specific individual psychosocial vulnerabilities.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1716253"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1744947
Lena Spangenberg, Cora Spahn, Jana Serebriakova, Thomas Forkmann, Heide Glaesmer
Background: This study explored participant experiences with ecological momentary assessment (EMA) in the context of suicidal thoughts and behaviors (STBs).
Methods: 16 participants of a long-term EMA study (with varying STB occurrence during the study and low vs. high compliance) were interviewed on reactivity effects and feasibility of EMA. Qualitative content analysis was performed using an inductive-deductive approach and consensual coding.
Results: Reactivity to EMA was reported by some participants, with suicidal thoughts occasionally intensifying/being triggered by survey prompts. Importantly, no evidence indicated that EMA triggered suicidal actions. However, the burden increased over time for some, calling for more personalized monitoring durations. EMA's feasibility during acute suicidal crises was questioned due to reduced ability and willingness to respond.
Conclusions: Long-term EMA monitoring after psychiatric discharge was perceived as feasible and beneficial. Selection bias and the lack of quantitative validation limit generalizability. Findings underscore the value of mixed-methods approaches and participatory protocol design.
{"title":"Qualitative content analysis of reactivity effects and feasibility of ecological momentary assessments of suicide-related thoughts and behaviors in the long-term and in suicidal crises.","authors":"Lena Spangenberg, Cora Spahn, Jana Serebriakova, Thomas Forkmann, Heide Glaesmer","doi":"10.3389/fpsyt.2026.1744947","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1744947","url":null,"abstract":"<p><strong>Background: </strong>This study explored participant experiences with ecological momentary assessment (EMA) in the context of suicidal thoughts and behaviors (STBs).</p><p><strong>Methods: </strong>16 participants of a long-term EMA study (with varying STB occurrence during the study and low vs. high compliance) were interviewed on reactivity effects and feasibility of EMA. Qualitative content analysis was performed using an inductive-deductive approach and consensual coding.</p><p><strong>Results: </strong>Reactivity to EMA was reported by some participants, with suicidal thoughts occasionally intensifying/being triggered by survey prompts. Importantly, no evidence indicated that EMA triggered suicidal actions. However, the burden increased over time for some, calling for more personalized monitoring durations. EMA's feasibility during acute suicidal crises was questioned due to reduced ability and willingness to respond.</p><p><strong>Conclusions: </strong>Long-term EMA monitoring after psychiatric discharge was perceived as feasible and beneficial. Selection bias and the lack of quantitative validation limit generalizability. Findings underscore the value of mixed-methods approaches and participatory protocol design.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1744947"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To examine abnormalities in EEG microstate dynamics in patients with major depressive disorder (MDD) and to explore their associations with anxiety and somatization symptoms.
Methods: We enrolled 30 patients with MDD and 40 healthy controls. Resting-state EEG was recorded and analyzed using microstate segmentation (classes A-D). Temporal parameters (mean duration, occurrence, time coverage, and transition probabilities) were compared between groups, and correlations with clinical symptoms (HAMD, HAMA, MADRS) were examined.
Results: Compared with controls, patients with MDD exhibited a significantly longer duration, higher occurrence, and greater time coverage of microstate C, while microstate B showed reduced occurrence and coverage. Transition probability analyses revealed fewer transitions from A to B, A to D, B to A, B to D, and D to A, and more transitions between C and D. Symptom correlations indicated that microstate B occurrence was positively associated with HAMD anxiety/somatization scores, while transitions from C to D and from D to C were negatively correlated with anxiety/somatization scores.
Conclusions: MDD is characterized by alterations in microstate B and C dynamics and disrupted transitions between C and D, some of which relate to symptom dimensions, suggesting that EEG microstate features may serve as potential neurophysiological markers in major depressive disorder.
{"title":"Altered EEG microstate associated with anxiety and somatization symptoms in major depressive disorder.","authors":"Qinfan Shan, Guisen Wu, Yuxuan Xiong, Qian Guo, Hao Hu, Fuxu Zhang, Zhenying Qian, Tianhong Zhang, Xiaohua Liu","doi":"10.3389/fpsyt.2026.1772171","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1772171","url":null,"abstract":"<p><strong>Objective: </strong>To examine abnormalities in EEG microstate dynamics in patients with major depressive disorder (MDD) and to explore their associations with anxiety and somatization symptoms.</p><p><strong>Methods: </strong>We enrolled 30 patients with MDD and 40 healthy controls. Resting-state EEG was recorded and analyzed using microstate segmentation (classes A-D). Temporal parameters (mean duration, occurrence, time coverage, and transition probabilities) were compared between groups, and correlations with clinical symptoms (HAMD, HAMA, MADRS) were examined.</p><p><strong>Results: </strong>Compared with controls, patients with MDD exhibited a significantly longer duration, higher occurrence, and greater time coverage of microstate C, while microstate B showed reduced occurrence and coverage. Transition probability analyses revealed fewer transitions from A to B, A to D, B to A, B to D, and D to A, and more transitions between C and D. Symptom correlations indicated that microstate B occurrence was positively associated with HAMD anxiety/somatization scores, while transitions from C to D and from D to C were negatively correlated with anxiety/somatization scores.</p><p><strong>Conclusions: </strong>MDD is characterized by alterations in microstate B and C dynamics and disrupted transitions between C and D, some of which relate to symptom dimensions, suggesting that EEG microstate features may serve as potential neurophysiological markers in major depressive disorder.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1772171"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1580635
Chidebe Christian Anikwe, Osita Samuel Umeononihu, Ifeyinwa Helen Anikwe, Cyril Chijioke Ikeoha, Arinze Chidiebele Ikeotuonye, Victor Nwabunwanne Oguaka, Chukwuemeka Jude Ofojebe, Chukwunonso Isaiah Enechukwu, Chidubem Philip Osuagwu, Nwabunike Ekene Okeke, Richard Lawrence Ewah, Mbanefo Paul Okeke
Background: The periods of pregnancy are critical for the mental well-being of women. HIV positive pregnant women are especially vulnerable to experiencing depression and anxiety.
Aim: To determine the prevalence and determinant of depression and anxiety among HIV-positive and HIV negative pregnant women in Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi, Nigeria.
Materials and methods: Between January 1 and May 30, 2024, 342 HIV-positive pregnant individuals and an equivalent number of HIV-negative prenatal attendees participated in a cross-sectional survey conducted at NAUTH in Nnewi. A structured questionnaire, the Generalized Anxiety Disorder Assessment, and the Patient Health Questionnaire were used to interview the subjects. IBM Statistical Package for Social Science version 26 was used to analyze the data, and a significance level of less than 0.05 was chosen.
Results: The research involved 684 participants, all of whom screened positive for anxiety and depression. The average scores for anxiety in HIV-positive and HIV-negative women were 16.8 ± 3.8 compared to 8.7 ± 2.3; P <0.001, while for depression the scores were 11.1 ± 4.3 versus 3.1 ± 3.3; P < 0.001, respectively. A significant presence of major depressive and anxiety disorders was discovered among HIV-positive women, with moderate and severe depression affecting 47.7% and 21.9%, respectively, while moderate and severe anxiety were observed in 21.3% and 73.6% of the women. The majority of women in the control group exhibited mild mental health disorders. For HIV-positive women, the significant factors influencing depression included being 30 years old or younger, having a gestational age of 30 weeks or less, possessing a lower educational level, being employed, and being married; for anxiety, key factors were being para 0-3, experiencing psychological IPV, and being married. Among HIV-negative women, significant determinants of depression included being 30 years old or younger, having a low educational level, and being married.
Conclusion: The prevalence of mental health disorders in the study group is extremely high. The rate is unacceptably elevated among pregnant women who are HIV-positive. This emphasizes the need to integrate mental health services into standard maternal healthcare for all women, especially those living with HIV.
背景:怀孕期对女性的心理健康至关重要。艾滋病毒阳性的孕妇特别容易感到抑郁和焦虑。目的:了解尼日利亚Nnamdi Azikiwe大学教学医院(NAUTH) HIV阳性和HIV阴性孕妇中抑郁和焦虑的患病率及其决定因素。材料和方法:在2024年1月1日至5月30日期间,342名hiv阳性孕妇和同等数量的hiv阴性产前参与者参加了在Nnewi的NAUTH进行的横断面调查。采用结构化问卷、《广泛性焦虑障碍评估》和《患者健康问卷》对受试者进行访谈。采用IBM Statistical Package for Social Science version 26对数据进行分析,选取显著性水平小于0.05。结果:该研究涉及684名参与者,他们的焦虑和抑郁筛查均呈阳性。hiv阳性和hiv阴性妇女的焦虑平均得分分别为16.8±3.8分和8.7±2.3分;结论:研究组精神健康障碍患病率极高。在艾滋病毒呈阳性的孕妇中,这一比率高得令人无法接受。这强调需要将精神保健服务纳入所有妇女,特别是艾滋病毒感染者的标准孕产妇保健。
{"title":"An assessment of anxiety and depression among HIV-positive pregnant women in a tertiary hospital located in southeast Nigeria: a cross-sectional comparative analysis.","authors":"Chidebe Christian Anikwe, Osita Samuel Umeononihu, Ifeyinwa Helen Anikwe, Cyril Chijioke Ikeoha, Arinze Chidiebele Ikeotuonye, Victor Nwabunwanne Oguaka, Chukwuemeka Jude Ofojebe, Chukwunonso Isaiah Enechukwu, Chidubem Philip Osuagwu, Nwabunike Ekene Okeke, Richard Lawrence Ewah, Mbanefo Paul Okeke","doi":"10.3389/fpsyt.2026.1580635","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1580635","url":null,"abstract":"<p><strong>Background: </strong>The periods of pregnancy are critical for the mental well-being of women. HIV positive pregnant women are especially vulnerable to experiencing depression and anxiety.</p><p><strong>Aim: </strong>To determine the prevalence and determinant of depression and anxiety among HIV-positive and HIV negative pregnant women in Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi, Nigeria.</p><p><strong>Materials and methods: </strong>Between January 1 and May 30, 2024, 342 HIV-positive pregnant individuals and an equivalent number of HIV-negative prenatal attendees participated in a cross-sectional survey conducted at NAUTH in Nnewi. A structured questionnaire, the Generalized Anxiety Disorder Assessment, and the Patient Health Questionnaire were used to interview the subjects. IBM Statistical Package for Social Science version 26 was used to analyze the data, and a significance level of less than 0.05 was chosen.</p><p><strong>Results: </strong>The research involved 684 participants, all of whom screened positive for anxiety and depression. The average scores for anxiety in HIV-positive and HIV-negative women were 16.8 ± 3.8 compared to 8.7 ± 2.3; P <0.001, while for depression the scores were 11.1 ± 4.3 versus 3.1 ± 3.3; P < 0.001, respectively. A significant presence of major depressive and anxiety disorders was discovered among HIV-positive women, with moderate and severe depression affecting 47.7% and 21.9%, respectively, while moderate and severe anxiety were observed in 21.3% and 73.6% of the women. The majority of women in the control group exhibited mild mental health disorders. For HIV-positive women, the significant factors influencing depression included being 30 years old or younger, having a gestational age of 30 weeks or less, possessing a lower educational level, being employed, and being married; for anxiety, key factors were being para 0-3, experiencing psychological IPV, and being married. Among HIV-negative women, significant determinants of depression included being 30 years old or younger, having a low educational level, and being married.</p><p><strong>Conclusion: </strong>The prevalence of mental health disorders in the study group is extremely high. The rate is unacceptably elevated among pregnant women who are HIV-positive. This emphasizes the need to integrate mental health services into standard maternal healthcare for all women, especially those living with HIV.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1580635"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1681452
Maria Loizidou, Ioulia Solomou, Flora Nikolaou, Fofi Constantinidou
Introduction: Brain fog describes a heterogenous symptom encompassing cognitive symptoms, mental fatigue and reduced mental clarity, particularly prevalent among individuals with Post COVID - 19 Condition (PCC). This study aimed to translate and validate the Brain Fog Scale (BFS), originally developed in Polish, among a Greek-speaking population and explore whether individuals diagnosed with PCC report significantly more brain fog symptoms, compared to those without PCC.
Methods: The BFS was translated in Greek, using a forward - backward translation process and was administered online. Principal Component Analysis and Confirmatory Factor Analysis were run to assess factor structure.
Results: A total of 602 individuals (76.6% female) completed the BFS, of which 36 had a self-reported diagnosis of PCC. Internal consistency for the entire sample was excellent, α = 0.96. The BFS largely retained its original three factor structure with little variability: (1) impaired cognitive acuity (α = 0.95), (2) inattentiveness (α = 0.92), (3) mental exhaustion (α = 0.84). A Mann-Whitney U test revealed that individuals diagnosed with PCC reported significantly more brain fog symptoms compared to those without PCC, U = 2178.50, p = .011. MANOVA analyses further indicated significantly higher scores in the impaired cognition Factor among individuals with PCC, F(1, 125) = 7.32, p = .008.
Conclusion: The BFS comprises a valid tool for assessment of brain fog and can facilitate person-centred rehabilitation planning in PCC. Findings are discussed in relation to the literature regarding brain fog symptom burden in PCC with suggestions for future research made.
{"title":"Brain fog symptoms in individuals with and without post COVID-19 condition: translation and validation of the brain fog scale.","authors":"Maria Loizidou, Ioulia Solomou, Flora Nikolaou, Fofi Constantinidou","doi":"10.3389/fpsyt.2026.1681452","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1681452","url":null,"abstract":"<p><strong>Introduction: </strong>Brain fog describes a heterogenous symptom encompassing cognitive symptoms, mental fatigue and reduced mental clarity, particularly prevalent among individuals with Post COVID - 19 Condition (PCC). This study aimed to translate and validate the Brain Fog Scale (BFS), originally developed in Polish, among a Greek-speaking population and explore whether individuals diagnosed with PCC report significantly more brain fog symptoms, compared to those without PCC.</p><p><strong>Methods: </strong>The BFS was translated in Greek, using a forward - backward translation process and was administered online. Principal Component Analysis and Confirmatory Factor Analysis were run to assess factor structure.</p><p><strong>Results: </strong>A total of 602 individuals (76.6% female) completed the BFS, of which 36 had a self-reported diagnosis of PCC. Internal consistency for the entire sample was excellent, α = 0.96. The BFS largely retained its original three factor structure with little variability: (1) impaired cognitive acuity (α = 0.95), (2) inattentiveness (α = 0.92), (3) mental exhaustion (α = 0.84). A Mann-Whitney U test revealed that individuals diagnosed with PCC reported significantly more brain fog symptoms compared to those without PCC, <i>U</i> = 2178.50, <i>p</i> = .011. MANOVA analyses further indicated significantly higher scores in the impaired cognition Factor among individuals with PCC, <i>F</i>(1, 125) = 7.32, <i>p</i> = .008.</p><p><strong>Conclusion: </strong>The BFS comprises a valid tool for assessment of brain fog and can facilitate person-centred rehabilitation planning in PCC. Findings are discussed in relation to the literature regarding brain fog symptom burden in PCC with suggestions for future research made.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1681452"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1756782
Daniel A Lopez, Arturo Lopez-Flores, Sara Shao, Bonnie J Nagel
Objective: Children with ADHD are at increased risk for developing gaming addiction, but the psychosocial mechanisms underlying this relationship remain poorly understood. This study aimed to identify factors that mediate this risk.
Method: We analyzed data from three consecutive waves (Years 2-4) of the Adolescent Brain Cognitive DevelopmentSM (ABCD®) Study, including approximately 7,260 participants. Linear mixed-effects models were used to assess the longitudinal association between ADHD diagnosis (measured via the Kiddie Schedule for Affective Disorders and Schizophrenia [KSADS]) and scores on the Video Game Addiction Questionnaire (VGAQ). A parallel mediation model was then employed to evaluate the role of nine psychosocial factors in mediating this relationship.
Results: Children with ADHD had significantly higher VGAQ scores over time, with an average increase of 1.3 points (p < 0.001) compared to those without ADHD. The mediation model identified three significant psychosocial mediators: prosocial peer involvement (7.4% of the total effect), school involvement (5.8%), and family conflict (5.1%).
Conclusion: Prosocial peer involvement, school engagement, and family conflict emerged as key psychosocial pathways linking ADHD to gaming addiction. These findings have important public health implications and suggest that strengthening peer networks and family environments may be effective targets for intervention in children with ADHD.
{"title":"ADHD and gaming addiction in adolescents: psychosocial mediators in the adolescent brain cognitive development study.","authors":"Daniel A Lopez, Arturo Lopez-Flores, Sara Shao, Bonnie J Nagel","doi":"10.3389/fpsyt.2026.1756782","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1756782","url":null,"abstract":"<p><strong>Objective: </strong>Children with ADHD are at increased risk for developing gaming addiction, but the psychosocial mechanisms underlying this relationship remain poorly understood. This study aimed to identify factors that mediate this risk.</p><p><strong>Method: </strong>We analyzed data from three consecutive waves (Years 2-4) of the Adolescent Brain Cognitive Development<sup>SM</sup> (ABCD<sup>®</sup>) Study, including approximately 7,260 participants. Linear mixed-effects models were used to assess the longitudinal association between ADHD diagnosis (measured via the Kiddie Schedule for Affective Disorders and Schizophrenia [KSADS]) and scores on the Video Game Addiction Questionnaire (VGAQ). A parallel mediation model was then employed to evaluate the role of nine psychosocial factors in mediating this relationship.</p><p><strong>Results: </strong>Children with ADHD had significantly higher VGAQ scores over time, with an average increase of 1.3 points (<i>p</i> < 0.001) compared to those without ADHD. The mediation model identified three significant psychosocial mediators: prosocial peer involvement (7.4% of the total effect), school involvement (5.8%), and family conflict (5.1%).</p><p><strong>Conclusion: </strong>Prosocial peer involvement, school engagement, and family conflict emerged as key psychosocial pathways linking ADHD to gaming addiction. These findings have important public health implications and suggest that strengthening peer networks and family environments may be effective targets for intervention in children with ADHD.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1756782"},"PeriodicalIF":3.2,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-05eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1756576
Hesed Virto-Farfan, Fritz Fidel Váscones-Román, Valeria Rivera, Olga Karpenko, Elena Bochkina, Ekaterina Parshakova, Alexey Sinev, Gustavo E Tafet, Niels Pacheco-Barrios
<p><strong>Introduction: </strong>Combat-related post-traumatic stress disorder (PTSD) remains highly prevalent among military personnel and veterans and is frequently chronic, disabling, and only partially responsive to first-line pharmacological and psychotherapeutic interventions. Given the central role of fronto-limbic circuit dysfunction in PTSD, transcranial magnetic stimulation (TMS) has emerged as a biologically plausible neuromodulatory strategy, yet its protocol-level efficacy in combat-exposed populations is not well established. Clarifying whether specific TMS modalities offer clinically meaningful benefit beyond sham, and whether any protocol can be prioritized, is critical for rationally integrating TMS into veteran-focused care pathways.</p><p><strong>Methods: </strong>This systematic review and meta-analysis followed PRISMA 2020 and Cochrane Handbook recommendations and was prospectively registered in PROSPERO (CRD420251105555). We searched PubMed, SCOPUS, Embase, Web of Science, and EBSCO (March-June 2025) for clinical studies of adults with combat-related PTSD (DSM-IV, DSM-5, ICD-10, or ICD-11) receiving any TMS modality (rTMS, theta-burst stimulation, deep TMS, synchronized or accelerated TMS), compared with sham, standard care, or both. Primary outcomes were changes in PTSD severity measured with validated instruments (e.g., CAPS, PCL-5); secondary outcomes included depressive and anxiety symptoms, psychosocial functioning, acceptability, and safety. Random-effects meta-analyses (DerSimonian-Laird) were conducted for within-group pre-post change and between-group mean differences (TMS vs. control); heterogeneity was quantified with I². Risk of bias in randomized trials was assessed using the Cochrane RoB 2.0 tool.</p><p><strong>Results: </strong>From 191 records, 7 studies (n = 963) were included in the quantitative synthesis. Five studies contributed pre-post data (including one of the randomized controlled trial that presented the pre and post data of the TMS group), showing a large, clinically meaningful pooled reduction in PTSD symptoms after TMS (pooled mean change -20.39 points; 95% CI -23.94 to -16.83; p < 0.001; I² = 88.7), with the greatest improvements observed in high-frequency (10 Hz) left DLPFC rTMS protocols delivered over 20-30 sessions. In contrast, three randomized controlled trials (n = 116) comparing active TMS with sham yielded a non-significant pooled mean difference favoring TMS (MD -3.83; 95% CI -16.32 to 8.65; p = 0.098; I² = 56.9), suggesting that a substantial portion of symptom improvement may reflect non-specific or shared therapeutic factors. Subgroup analyses hinted at benefit for conventional rTMS and inconclusive effects for deep TMS, but were underpowered and did not identify any modality as clearly superior. Across studies, TMS was well tolerated: no serious adverse events were reported, dropout rates were low (~7%), and adverse effects were predominantly mild (transient headache, scalp discom
战斗相关的创伤后应激障碍(PTSD)在军人和退伍军人中仍然非常普遍,并且通常是慢性的,致残的,并且仅对一线药物和心理治疗干预有部分反应。鉴于额边缘回路功能障碍在创伤后应激障碍中的核心作用,经颅磁刺激(TMS)已成为一种生物学上合理的神经调节策略,但其在战斗暴露人群中的协议级疗效尚未得到很好的确立。明确特定的经颅磁刺激模式是否能提供比假手术更有临床意义的益处,以及是否有任何方案可以优先考虑,对于合理地将经颅磁刺激纳入以退伍军人为重点的护理途径至关重要。方法:本系统评价和荟萃分析遵循PRISMA 2020和Cochrane手册的建议,并在PROSPERO (CRD420251105555)中前瞻性注册。我们检索了PubMed, SCOPUS, Embase, Web of Science和EBSCO(2025年3 - 6月),以获得接受任何经颅刺激方式(rTMS,脑波刺激,深度TMS,同步或加速TMS)的成人战斗相关PTSD (DSM-IV, DSM-5, ICD-10或ICD-11)的临床研究,与假手术,标准治疗或两者相比较。主要结局是使用经过验证的仪器(如CAPS、PCL-5)测量PTSD严重程度的变化;次要结局包括抑郁和焦虑症状、社会心理功能、可接受性和安全性。随机效应荟萃分析(dersimonan - laird)用于组内前后变化和组间平均差异(经颅磁刺激组与对照组);异质性用I²量化。使用Cochrane RoB 2.0工具评估随机试验的偏倚风险。结果:191篇文献中有7篇(n = 963)纳入定量综合。五项研究提供了前后数据(包括一项随机对照试验,提供了经颅磁刺激组前后数据),显示经颅磁刺激后创伤后应激障碍症状有显著的临床意义的综合减少(综合平均变化-20.39点;95% CI -23.94至-16.83;p < 0.001; I²= 88.7),其中在高频(10 Hz)左DLPFC rTMS方案中观察到的改善最大,超过20-30次。相比之下,三个随机对照试验(n = 116)比较有效经颅磁刺激与假经颅磁刺激,得出的合并平均差异不显著(MD -3.83; 95% CI -16.32至8.65;p = 0.098; I²= 56.9),表明症状改善的很大一部分可能反映了非特异性或共享的治疗因素。亚组分析暗示常规rTMS有益,而深度TMS效果不确定,但效果不足,也没有确定任何一种方式明显优于深度TMS。在所有研究中,经颅磁刺激的耐受性良好:没有严重不良事件的报道,辍学率低(~7%),不良反应主要是轻微的(短暂性头痛,头皮不适,疲劳)。总的来说,有证据表明,经颅刺激在治疗与战斗相关的创伤后应激障碍方面具有强大的组内临床改善和良好的安全性,但与假手术相比,单独的经颅刺激方案的具体优势和相对优势仍不确定,这表明需要进行更大规模的、以方案为中心的随机试验,并进行标准化参数和更长的随访。系统评审注册:https://www.crd.york.ac.uk/PROSPERO/view/CRD420251105555,标识符CRD420251105555。
{"title":"Efficacy of transcranial magnetic stimulation in the treatment of combat-related PTSD: a systematic review and meta-analysis.","authors":"Hesed Virto-Farfan, Fritz Fidel Váscones-Román, Valeria Rivera, Olga Karpenko, Elena Bochkina, Ekaterina Parshakova, Alexey Sinev, Gustavo E Tafet, Niels Pacheco-Barrios","doi":"10.3389/fpsyt.2026.1756576","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1756576","url":null,"abstract":"<p><strong>Introduction: </strong>Combat-related post-traumatic stress disorder (PTSD) remains highly prevalent among military personnel and veterans and is frequently chronic, disabling, and only partially responsive to first-line pharmacological and psychotherapeutic interventions. Given the central role of fronto-limbic circuit dysfunction in PTSD, transcranial magnetic stimulation (TMS) has emerged as a biologically plausible neuromodulatory strategy, yet its protocol-level efficacy in combat-exposed populations is not well established. Clarifying whether specific TMS modalities offer clinically meaningful benefit beyond sham, and whether any protocol can be prioritized, is critical for rationally integrating TMS into veteran-focused care pathways.</p><p><strong>Methods: </strong>This systematic review and meta-analysis followed PRISMA 2020 and Cochrane Handbook recommendations and was prospectively registered in PROSPERO (CRD420251105555). We searched PubMed, SCOPUS, Embase, Web of Science, and EBSCO (March-June 2025) for clinical studies of adults with combat-related PTSD (DSM-IV, DSM-5, ICD-10, or ICD-11) receiving any TMS modality (rTMS, theta-burst stimulation, deep TMS, synchronized or accelerated TMS), compared with sham, standard care, or both. Primary outcomes were changes in PTSD severity measured with validated instruments (e.g., CAPS, PCL-5); secondary outcomes included depressive and anxiety symptoms, psychosocial functioning, acceptability, and safety. Random-effects meta-analyses (DerSimonian-Laird) were conducted for within-group pre-post change and between-group mean differences (TMS vs. control); heterogeneity was quantified with I². Risk of bias in randomized trials was assessed using the Cochrane RoB 2.0 tool.</p><p><strong>Results: </strong>From 191 records, 7 studies (n = 963) were included in the quantitative synthesis. Five studies contributed pre-post data (including one of the randomized controlled trial that presented the pre and post data of the TMS group), showing a large, clinically meaningful pooled reduction in PTSD symptoms after TMS (pooled mean change -20.39 points; 95% CI -23.94 to -16.83; p < 0.001; I² = 88.7), with the greatest improvements observed in high-frequency (10 Hz) left DLPFC rTMS protocols delivered over 20-30 sessions. In contrast, three randomized controlled trials (n = 116) comparing active TMS with sham yielded a non-significant pooled mean difference favoring TMS (MD -3.83; 95% CI -16.32 to 8.65; p = 0.098; I² = 56.9), suggesting that a substantial portion of symptom improvement may reflect non-specific or shared therapeutic factors. Subgroup analyses hinted at benefit for conventional rTMS and inconclusive effects for deep TMS, but were underpowered and did not identify any modality as clearly superior. Across studies, TMS was well tolerated: no serious adverse events were reported, dropout rates were low (~7%), and adverse effects were predominantly mild (transient headache, scalp discom","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1756576"},"PeriodicalIF":3.2,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12999802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-05eCollection Date: 2026-01-01DOI: 10.3389/fpsyt.2026.1773598
Kiran Boone, Jessica LaRocca, Kennedy M Balzen, Carla Sharp, Dara E Babinski
Given the research consensus that personality disorder often onsets in adolescence, more work is needed to investigate parent-child discrepancies in reporting on personality disorder, particularly during the pre- and early adolescent period when more significant impairment in personality functioning may be developing or can already be observed. The current study examined concordance of parent- and child-reported level of personality functioning (LPF, as defined in the DSM-5 Alternative Model of Personality Disorders) among pre- and early adolescents and examined the extent to which this concordance was associated with clinically relevant outcomes. Participants included N = 432 children between the ages of 10 and 15 years from three samples oversampled for psychopathology symptoms and their parents. Children and their parents reported on child impairment in personality functioning with the Level of Personality Functioning Scale Brief Form 2.0. Outcomes included parent-reported caregiver strain, parent-reported child functional impairment, and child-reported history of thoughts and behaviors related to suicide and non-suicidal self-injury. Latent profile analysis was conducted to identify profiles of children based on patterns of convergence and divergence between parent- and child-reported LPF. Profile membership was then used to predict outcomes. A four-profile model, with two parent-child convergent and two parent-child divergent profiles, demonstrated the best fit. Convergence on high impairment in LPF demonstrated the strongest associations with outcomes. Divergent profiles also demonstrated stronger associations with outcomes reported by the informant who had endorsed higher impairment in LPF. Findings suggested that both parent- and child-reported LPF, and the degree of their concordance, may have unique value for predicting clinically important outcomes in pre- and early adolescence. Research and clinical practice utilizing new dimensional approaches with adolescents may therefore benefit from multi-informant assessment of personality functioning.
{"title":"Parent-child discrepancies in reports of pre- and early adolescent level of personality functioning.","authors":"Kiran Boone, Jessica LaRocca, Kennedy M Balzen, Carla Sharp, Dara E Babinski","doi":"10.3389/fpsyt.2026.1773598","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1773598","url":null,"abstract":"<p><p>Given the research consensus that personality disorder often onsets in adolescence, more work is needed to investigate parent-child discrepancies in reporting on personality disorder, particularly during the pre- and early adolescent period when more significant impairment in personality functioning may be developing or can already be observed. The current study examined concordance of parent- and child-reported level of personality functioning (LPF, as defined in the DSM-5 Alternative Model of Personality Disorders) among pre- and early adolescents and examined the extent to which this concordance was associated with clinically relevant outcomes. Participants included <i>N</i> = 432 children between the ages of 10 and 15 years from three samples oversampled for psychopathology symptoms and their parents. Children and their parents reported on child impairment in personality functioning with the Level of Personality Functioning Scale Brief Form 2.0. Outcomes included parent-reported caregiver strain, parent-reported child functional impairment, and child-reported history of thoughts and behaviors related to suicide and non-suicidal self-injury. Latent profile analysis was conducted to identify profiles of children based on patterns of convergence and divergence between parent- and child-reported LPF. Profile membership was then used to predict outcomes. A four-profile model, with two parent-child convergent and two parent-child divergent profiles, demonstrated the best fit. Convergence on high impairment in LPF demonstrated the strongest associations with outcomes. Divergent profiles also demonstrated stronger associations with outcomes reported by the informant who had endorsed higher impairment in LPF. Findings suggested that both parent- and child-reported LPF, and the degree of their concordance, may have unique value for predicting clinically important outcomes in pre- and early adolescence. Research and clinical practice utilizing new dimensional approaches with adolescents may therefore benefit from multi-informant assessment of personality functioning.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1773598"},"PeriodicalIF":3.2,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12999937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}